Alaunos Therapeutics Stock (NASDAQ: TCRT) stock price, news, charts, stock research, profile.
Open | $0.72 |
Close | $0.70 |
Volume / Avg. | 35.34K / 44.63K |
Day Range | 0.66 - 0.73 |
52 Wk Range | 0.61 - 7.80 |
Market Cap | $11.21M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 10.18% |
Days to Cover | 67.75 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alaunos Therapeutics (NASDAQ:TCRT) through any online brokerage.
Other companies in Alaunos Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
There is no analysis for Alaunos Therapeutics.
Alaunos Therapeutics has a consensus price target of $1.80.
The stock price for Alaunos Therapeutics (NASDAQ: TCRT) is $0.7 last updated June 26, 2024 at 4:35 PM EDT.
There are no upcoming dividends for Alaunos Therapeutics.
Alaunos Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Alaunos Therapeutics.
Alaunos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.